Do GLP-1 drugs really make birth control fail and cause surprise pregnancies?

What did @primal_health_wellness actually say?

The creator made two core arguments. First, that GLP-1 medications cause "ineffectiveness" of oral contraceptives by slowing gastric emptying, reducing pill absorption, and leading to unintended pregnancies. Second, that GLP-1 drugs restore fertility indirectly by improving insulin resistance, reducing cortisol, and resolving PCOS-related hormonal dysfunction. They encouraged followers to share pregnancy stories in the comments, framing this as an emerging pattern across their client base.

The creator also claimed that providers "should have been asked" about pregnancy risk during GLP-1 screening, implying this is a standard but frequently missed step. Both arguments carry real kernels of truth, but the way they were stitched together overstates the evidence and misrepresents the mechanism behind at least one of those claims.

Does the science back this up?

Partially, but the gastric emptying argument is weaker than the creator implies. The FDA-approved labeling for semaglutide does note that it slows gastric emptying, which could theoretically reduce the absorption rate of co-administered oral medications. However, the clinical data on oral contraceptives specifically is thin.

A pharmacokinetic substudy in the SUSTAIN trial program (Hausner et al., 2023, Clinical Pharmacokinetics) found that semaglutide caused modest reductions in the Cmax of ethinyl estradiol and levonorgestrel, but AUC values, the metric that actually reflects total drug exposure and efficacy, were not significantly affected. The European Medicines Agency reviewed this and concluded that oral contraceptive efficacy was not meaningfully compromised. That is not the same as saying there is zero risk. It means the mechanism the creator describes does not translate cleanly into documented contraceptive failure at the clinical level.

The fertility restoration argument is better supported. Multiple observational studies, including work by Palomba et al. (2021, Human Reproduction Update), confirm that weight loss and improved insulin sensitivity in women with PCOS can restore ovulatory cycles that had been suppressed by metabolic dysfunction. GLP-1 drugs that drive that weight loss could plausibly mediate the same effect.

What did they get wrong (or right)?

The creator gets credit for flagging the PCOS and insulin resistance angle. That part is grounded in real endocrinology. Women with PCOS who were previously anovulatory due to obesity or insulin resistance can become unexpectedly fertile as metabolic markers improve, and this is a legitimate clinical concern that deserves more airtime.

Where they go wrong is on the cortisol claim. The statement that improving A1c control causes "decreasing or depleting that cortisol" is not physiologically accurate as described. Cortisol and A1c do interact, chronic hypercortisolism worsens insulin resistance, but normalizing glucose does not simply "deplete" cortisol. The mechanism is more complex and the creator's version of it is garbled enough to be misleading.

The framing that GLP-1 drugs are a "gastric emptying delay drug" as their primary identity is also reductive. These are receptor agonists with systemic metabolic, appetite, and neurological effects. Reducing them to one mechanism understates how they work and makes the contraceptive interaction sound more straightforward than it is.

The anecdote-as-evidence approach, citing "numerous clients" and asking followers to confirm with their own pregnancy stories, is the most troubling element. That is not how you establish a drug interaction signal. It is how you build a compelling TikTok.

What should you actually know?

If you are on a GLP-1 medication and relying on oral contraceptives, the most evidence-based recommendation from prescribing guidelines is to use a non-oral backup method, such as a condom or patch, for at least four weeks after starting or escalating your GLP-1 dose. This is a precautionary recommendation, not a confirmation that pills stop working entirely.

The fertility restoration pathway is real and underappreciated. If you have PCOS, a history of irregular cycles, or were told pregnancy was unlikely due to metabolic factors, starting a GLP-1 medication could change that picture faster than you expect. This is something to discuss with your prescriber before starting therapy, not after a missed period.

GLP-1 drugs are not approved for use during pregnancy. Both semaglutide and tirzepatide carry guidance recommending discontinuation before conception and are not recommended during pregnancy based on animal studies showing fetal harm. If you are pregnant or planning to become pregnant, that conversation with your provider cannot wait.

Bottom line

This video raises a legitimate public health issue but packages it with shaky mechanistic claims and zero citations. The "Ozempic baby" concern is real enough that the FDA label addresses it. But the creator's explanation of why it happens, especially the cortisol claim and the overstated contraceptive failure mechanism, does not hold up to scrutiny. Use this as a starting point for a conversation with your provider, not as clinical guidance.